Exagen Inc. Announces $26.2 Million Debt Refinancing

NEXT STORY
Sensus Healthcare to Present at the Piper Jaffray 31st Annual Healthcare Conference
PREV STORY
VBL Therapeutics to Present Data on New Investigator-Sponsored Phase 2 Trial of VB-111 in Recurrent Glioblastoma at the 2019 Society for Neuro-Oncology Annual Meeting
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Crown Bioscience Announces Merger with JSR Corporation

SAN DIEGO, Dec. 21, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of ...

author_avatar
NASDAQ Market News

Intercept Announces Winners of Practice to Policy Health Awards Program to Encourage New Research and Improve Care for People Living with PBC

NEW YORK, April 16, 2016 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals Inc. (Nasdaq:ICPT), a clinical stage ...

author_avatar
NASDAQ Market News

Momenta Pharmaceuticals to Webcast Presentation at the Goldman Sachs 37th Annual Global Healthcare Conference

CAMBRIDGE, Mass., May 25, 2016 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA), a biotechnology ...

author_avatar
NASDAQ Market News